| Cas No.: | 1152311-62-0 |
| 名称: | Cyclopropanecarboxamide, 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]- |
| 别名: | VX 661; VX661,VX-661 |
| SMILES: | C(C1=CC=C2OC(F)(F)OC2=C1)(C(NC1C(F)=CC2=C(C=1)C=C(C(C)(C)CO)N2C[C@H](O)CO)=O)1CC1 |
| 分子式: | C26H27F3N2O6 |
| 分子量: | 520.5 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | VX-661, known as a CTFR corrector, allows F508del mutant channels to escape degradation and transit to the cell membrane.For the detailed information of VX661, the solubility of VX661 in water, the solubility of VX661 in DMSO, the solubility of VX661 in P |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
